Profile
Paul Kenna is the founder of Spark Therapeutics Ireland Ltd. He is currently the Director-Ocular Genetics Unit at Trinity College Dublin since 2011.
Additionally, he holds positions as a Member at The Royal College of Physicians and the Irish College of Ophthalmologists.
Dr. Kenna obtained a doctorate degree from Trinity College Dublin.
Paul Kenna active positions
| Companies | Position | Start |
|---|---|---|
Spark Therapeutics Ireland Ltd.
Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Develops new gene medicines to treat autosomal dominant genetic diseases | Founder | - |
Trinity College Dublin
Trinity College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Irish College of Ophthalmologists
Irish College of Ophthalmologists Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Training of Paul Kenna
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Trinity College Dublin
Trinity College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spark Therapeutics Ireland Ltd.
Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Develops new gene medicines to treat autosomal dominant genetic diseases | Health Technology |
Irish College of Ophthalmologists
Irish College of Ophthalmologists Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Paul Kenna
















